Nebenwirkungen · Quadramet
Quadramet 1.3 GBq/mL solution for injection. · Abschnitt 4.8 · PDF-Seite 6
HOS-087453 · Präparat HOS-083495
System Organ Class Frequency Adverse reactions Blood and lymphatic system Very Common Thrombocytopenia2 disorders Anaemia2 Leukopenia2 Uncommon Disseminated intravascular coagulation2 Bone marrow failure 2 Immune system disorders Not known Hypersensitivity1 Anaphylactic reaction1 Metabolism and nutrition Uncommon Anorexia disorders Nervous system disorders Uncommon Haemorrhage intracranial Cerebrovascular accident 2 Spinal cord compression 2 Common Dizziness Gastrointestinal disorders Common Nausea Uncommon Vomiting Not known Diarrhoea1 Skin and subcutaneous tissue Uncommon Hyperhidrosis disorders Musculoskeletal and connective Common Bone pain 2 tissue disorders General Disorders and Common Asthenia administration site conditions 1 Adverse reactions from spontaneous reporting 2 See section Description of selected adverse reactions
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-10-31T14:00:00Z · SHA-256 82efe65778c242182a4d448b2f4bb96ae66ce957fc21e53e2c3aa178d7307937 · Passage 52f66fbc9f100d017b3c0bda0b2f87aadc616524f6a43210d364d377cd08420f · Zeichen 980–2947 im Abschnitt